Christopher Rhodes, PhDPresident and CEO at Drug Delivery Experts
Dr. Rhodes is CEO and founder of Drug Delivery Experts, a contract services product development CDMO specializing in solution through complex injectables and small molecules through biologics with capabilities from formulation through clinical supplies and stability. Dr. Rhodes is a pharmaceutical scientist with over 25 years of experience in product development of complex formulations and delivery systems including long-acting injectable, pulmonary, nasal, transdermal, and oral formulations for peptides, proteins, antibodies, oligonucleotides, and small molecules. He played a key role in the development of the commercial products Byetta, Lusedra, Bydureon, Myalept, and Afrezza, was an R&D leader at Amydis Diagnostics, SKS Ocular, Amylin, Guilford, and Mannkind, and was drug development team leader for a propofol prodrug, an NCE for peripheral neuropathy, and led translational research on delivery systems for exenatide, including nasal, pulmonary, oral, and transdermal microporation technologies. He is a founder of Sensulin, CASS Pharmaceuticals, and Baywind Bioventures, companies developing drug delivery enabled pharmaceutical assets. He has a PhD in chemistry (UCLA), a BS in chemistry (NYU), and was a Post Doc at Yale.